Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,018 | 124,287 | 143,736 | 151,794 | 280,119 |
| Marketable Securities | 470,500 | 657,036 | 606,350 | 847,123 | 677,954 |
| Receivables | N/A | N/A | N/A | 306 | 403 |
| Other current assets | 5,974 | 10,533 | 3,315 | 8,172 | 6,301 |
| TOTAL | $578,279 | $809,204 | $770,103 | $1,019,505 | $976,242 |
| Non-Current Assets | |||||
| PPE Net | 1,726 | 5,911 | 10,901 | 11,634 | 6,543 |
| Intangibles | 0 | 2,300 | 2,300 | 2,300 | 2,300 |
| Other Non-Current Assets | 41,326 | 53,881 | 60,676 | 66,332 | 23,358 |
| TOTAL | $43,052 | $62,092 | $73,877 | $80,266 | $32,201 |
| Total Assets | $621,331 | $871,296 | $843,980 | $1,099,771 | $1,008,443 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,705 | 14,097 | 9,211 | 10,578 | 8,276 |
| Accrued Expenses | 13,645 | 21,236 | 14,890 | 22,703 | 13,557 |
| Other current liabilities | 463 | 1,990 | 1,204 | 26,152 | 396 |
| TOTAL | $25,578 | $50,729 | $30,269 | $63,709 | $24,321 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 7,679 | N/A | N/A | 248 |
| Other Non-Current Liabilities | 28,693 | 42,775 | 61,708 | 85,844 | 86,314 |
| TOTAL | $28,693 | $42,775 | $61,708 | $85,844 | $86,314 |
| Total Liabilities | $54,271 | $93,504 | $91,977 | $149,553 | $110,635 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 178,726 | 169,522 | 131,179 | 121,385 | 108,280 |
| Common Shares | 168 | 168 | 127 | 121 | 109 |
| Retained earnings | -2,014,769 | -1,738,290 | -1,400,582 | -1,058,609 | -768,100 |
| Other shareholders' equity | 733 | -991 | -196 | -10,420 | -1,088 |
| TOTAL | $567,060 | $777,792 | $752,003 | $950,218 | $897,808 |
| Total Liabilities And Equity | $621,331 | $871,296 | $843,980 | $1,099,771 | $1,008,443 |